PATENT CLAIM ANALYSIS

Application Number: 15961394
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "252130"]

Abstract:
The present invention relates to dosing regimen of a new antimalarial drug, as monotherapy or combination therapy.

Claim (Index 7):
A method of preventing or treating malaria, or delaying the symptoms or ameliorating the conditions associated with malaria, in a subject in need thereof, comprising administering to said subject about 200 mg to 350 mg of 2-amino-1-(2-(4-fluorophenyl)-3-(4-fluorophenylamino)-8,8-dimethyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)ethanone, or a pharmaceutically acceptable salt thereof, delivered daily, during 1 to 5 days.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15741786', '15532280', '14978059', '12833909', '14332829']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7566799202005359
- 35 USC 102 Novelty (BERT): 0.5132174081364036
- Combined Prediction Score: 0.7323336689941227
- Mean Citation Score: 243.177624
- Max Citation Score: 278.0089
- Similarity Product: 180.859520600152

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test